According to Hsueh Po-ren, special assistant to the CEO, all of TaiGen's founders had long experience in research and development of new pharmaceuticals, but the NHRI focuses on basic research, which is of limited use when it comes to turning technology into marketable products, so the researchers decided to enter the business world in hopes of "starting from scratch to set up a full-blown pharmaceuticals manufacturing operation in Taiwan."
太景執行長特助薛博仁表示，當時一起創業的朋友都有豐富的新藥研發經驗，但考量國衛院的研究過於早期、基礎，對商品化新藥發展的助益相當有限，因此他們決定「下海」，希望「從無到有，在國內完整地把製藥流程走一遍。」